About BioPharm Communications
BioPharm Communications is a Healthcare company based in New Hope (United States) founded in 2005, and was acquired by Indegene in October 2025. Marketing services are provided to pharmaceutical and biopharma companies. The company has 37 employees. BioPharm Communications offers products and services including Always ON Network, Moments Solution, and Peer-Based Deep Education. Its focus areas include Biopharma Outsourcing, Consulting, Business and Market Access & HEOR. Its legal entity is BIOPHARM COMMUNICATIONS, LLC. Its competitors include Target RWE, Secura Bio and Hylant; 1 of its 3 listed competitors has raised funding.
Company details
BioPharm Communications was established in 2005 and is headquartered in New Hope, United States. Marketing services are delivered to firms in the pharmaceutical and biopharmaceutical sectors. Operations center on communication strategies, including content development and promotional support tailored to healthcare regulations. The focus remains on assisting clients with industry-specific outreach, drawing from over 15 years of sector experience. Geographic operations are primarily U.S.-based, supporting biopharma entities nationwide.
- Headquarters New Hope, United States
- Employees 37
- Stage Acquired
- SectorsHealthcare
- Phoneβ’β’β’β’ β’β’β’β’
- Website biopharmcommunications.com
- Social LinkedIn X Facebook Instagram
- Acquired by Omnicom Health Group (May 2016)
- Legal Name Biopharm Communications, Llc
Products & Services of BioPharm Communications
BioPharm Communications offers a comprehensive portfolio of products and services, including Always ON Network, Moments Solution, and Peer-Based Deep Education.
Drives reach and engagement for healthcare decision makers through digital channels.
Provides trigger-based opportunities to impact HCP decisions and behavior effectively.
Offers KOL-led programs for deep clinical education and brand message endorsement.
Funding Insights of BioPharm Communications
- Total Rounds 1
- Last Round Debt – Conventional β $18.5M
- First Round $18.5M
(Mar 2012)
- Investors Count 3
All 1 funding rounds of BioPharm Communications with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2012 | $18.5M | Debt – Conventional | β | β |
6 investors in total: 6 institutional.
Investors in BioPharm Communications
BioPharm Communications has secured backing from 6 investors, including venture fund investors. Prominent investors backing the company include Indegene, Southfield Capital and Abacus Finance.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Abacus Finance is engaged in providing tailored credit solutions to lower-middle market companies. | abacusfinance.com | New York, United States | ||
Private equity and debt investments are focused on multiple sectors. | boathousecapital.com | Wayne, United States | ||
| cmsmezz.com | ||||
Private equity investment firm | 2002 | southfieldcapital.com | Greenwich, United States | |
Suite solutions are provided for payers and healthcare providers. | 1998 | indegene.com | Princeton, United States | |
Global healthcare communications network uniting agencies for consulting and media services. | 2016 | omnicomhealthgroup.com | New York, United States |
Investor details for BioPharm Communications
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of BioPharm Communications
5 dated milestones of BioPharm Communications across 20 years, from founding to its latest funding, stage changes and deals.
- Founded BioPharm Communications is founded.
- Funding First funding round of $18.5M.
- Exit Acquired by Southfield Capital.
- Exit Acquired by Omnicom Health Group.
- Exit Acquired by Indegene.
Competitors of BioPharm Communications
BioPharm Communications has 3 listed competitors in our database, 1 of them funded. They include Target RWE, Secura Bio and Hylant.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| targetrwe.com | 2017 | Durham, United States | 116 | Marketing services to the pharmaceutical industry are provided. | ||
| securabio.com | 2018 | Henderson, United States | $55M | Consulting services for market access and health outcomes are provided. | ||
| hylant.com | 1935 | Toledo, United States | 849 | Offers business insurance, employee benefits, and risk consulting services worldwide. |
Detailed competitors of BioPharm Communications
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of BioPharm Communications
The website of BioPharm Communications (biopharmcommunications.com) receives about 1.1K visits a month.
- Monthly visits1.1K
▲ 57.8% vs previous month
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as BioPharm Communications (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 5,666 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about BioPharm Communications
BioPharm Communications was founded in 2005 and raised its 1st funding round 7 years after it was founded.
BioPharm Communications is headquartered in New Hope, United States.
BioPharm Communications has 37 employees.
BioPharm Communications was established in 2005 and is headquartered in New Hope, United States. Marketing services are delivered to firms in the pharmaceutical and biopharmaceutical sectors. Operations center on communication strategies, including content development and promotional support tailored to healthcare regulations. The focus remains on assisting clients with industry-specific outreach, drawing from over 15 years of sector experience. Geographic operations are primarily U.S.-based, supporting biopharma entities nationwide.
BioPharm Communications's top competitors include Target RWE, Secura Bio and Hylant.
BioPharm Communications offers Always ON Network, Moments Solution, and Peer-Based Deep Education.
BioPharm Communications has 6 investors. Key investors include Indegene, Southfield Capital, Abacus Finance, Boathouse Capital, and CMS Mezzanine Fund.
BioPharm Communications operates through Biopharm Communications, Llc.
Yes. BioPharm Communications was acquired by Omnicom Health Group in May 2016.
